IL-6 promotes malignant growth of skin SCCs by regulating a network of autocrine and paracrine cytokines

Int J Cancer. 2011 Jun 15;128(12):2803-14. doi: 10.1002/ijc.25621. Epub 2010 Nov 12.

Abstract

Cytokines play a crucial role in tumor initiation and progression. Here, we demonstrate that interleukin (IL)-6 is a key factor by driving tumor progression from benign to malignant, invasive tumors in the HaCaT-model of human skin carcinoma. IL-6 activates STAT3 and directly stimulates proliferation and migration of the benign noninvasive HaCaT-ras A-5 cells in vitro. Furthermore, IL-6 induces a complex, reciprocally regulated cytokine network in the tumor cells that includes inflammatory and angiogenic factors such as IL-8, GM-CSF, VEGF and MCP-1. These IL-6 effects lead to tumor cell invasion in organotypic cultures in vitro and to the formation of malignant and invasive s.c. tumors in vivo. Tumor invasion is supported by the IL-6 induced overexpression of MMP-1 in vitro and in vivo. These data demonstrate a key function of IL-6 in the progression of skin SCCs by regulating a complex cytokine and protease network and suggest new therapeutic approaches to target this central player in skin carcinogenesis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Base Sequence
  • Blotting, Western
  • Carcinoma, Squamous Cell / pathology*
  • Cell Proliferation
  • Cytokines / physiology*
  • DNA Primers
  • Disease Progression
  • Enzyme-Linked Immunosorbent Assay
  • Fluorescent Antibody Technique, Indirect
  • Humans
  • In Situ Hybridization
  • Interleukin-6 / physiology*
  • Neoplasm Invasiveness
  • Neoplasm Metastasis
  • STAT3 Transcription Factor / antagonists & inhibitors
  • Skin Neoplasms / pathology*

Substances

  • Cytokines
  • DNA Primers
  • Interleukin-6
  • STAT3 Transcription Factor
  • STAT3 protein, human